Related Experiment Video
Updated: Jul 6, 2026

10:16
Production and Targeting of Monovalent Quantum Dots
Published on: October 23, 2014
Design of biotin-functionalized luminescent quantum dots
Kimihiro Susumu1, H Tetsuo Uyeda, Igor L Medintz
1Division of Optical Sciences, U.S. Naval Research Laboratory, Washington, DC 20375, USA.
Journal of Biomedicine & Biotechnology
|April 3, 2008
Summary
We developed a new ligand, DHLA-TEG-biotin, to improve the biocompatibility of quantum dots (QDs). This ligand enables stable, water-dispersible QDs with specific biotin-NeutrAvidin interactions for assays.
Area of Science:
- Nanotechnology
- Materials Science
- Biochemistry
Background:
- Quantum dots (QDs) offer unique optical properties but often require surface modification for biological applications.
- Biocompatibility and aqueous dispersibility are critical challenges for QD implementation in biological systems.
Purpose of the Study:
- To design and synthesize a novel tetraethylene glycol- (TEG-) based ligand functionalized with dihydrolipoic acid (DHLA) and biotin.
- To enhance the biocompatibility and aqueous dispersibility of luminescent CdSe-ZnS core-shell quantum dots.
- To investigate the specific binding capabilities of the biotinylated QDs.
Main Methods:
- Synthesis of a DHLA-TEG-biotin ligand.
- Surface ligand exchange on CdSe-ZnS core-shell QDs.
- Dispersion of modified QDs in aqueous buffer solutions.
- Surface binding assays using NeutrAvidin-functionalized microtiter plates.
Main Results:
- The DHLA-TEG-biotin ligand successfully functionalized CdSe-ZnS QDs.
- QD solutions exhibited excellent dispersibility in aqueous buffers, with enhanced stability over a broad pH range when using DHLA-PEG600/DHLA-TEG-biotin mixtures.
- Surface binding assays confirmed specific interaction between the biotin groups on the QD surface and NeutrAvidin.
Conclusions:
- The novel DHLA-TEG-biotin ligand effectively promotes QD biocompatibility and aqueous stability.
- The biotinylation of QDs allows for specific surface interactions, paving the way for targeted bioassays and imaging applications.
- This approach offers a versatile platform for developing advanced QD-based biosensing technologies.

